Funded Projects › HORIZON
UNIFIED · Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies
Motivation: Failing to incorporate patient perspectives in healthcare decisions leads to sub-optimal care. Despite increasing emphasis from industry and policy-makers this is not yet common practice. Main objectives: UNIFIED is a public-private partnership involving universities, industry, patient groups, medical centres, HTA bodies, and clinical guideline organisations. It is designed to generate a UNIFIED Framework for obtaining a robust view of a health intervention’s full benefits to patients via (i) integrating three key data types: patient preference information, clinical outcome assessments, and digital health technology (DHT)-derived measures, and (ii) determining what patients consider minimum clinically important difference. Leveraging cutting-edge AI, particularly Foundation Models, UNIFIED integrates these diverse patient-centred data types reliably, while employing advanced safeguards. UNIFIED uses a structured, interactive, and multimethod approach, fostering synergy between academic expertise and fast experience in pharmaceutical and MedTech industry. Validation of the initial framework will occur through well-aligned complementary use cases in five medical domains across Europe and Canada and an adoption approach for patients, caregivers, clinicians, industry, regulatory/HTA/reimbursement bodies.Main deliverables: A robust evidence- and consensus-based UNIFIED Framework with recommendations for integrating patient-centred clinical-study endpoints. The framework will provide clear, actionable guidance for timely and effective use of patient-centred, DHT-derived data as clinical endpoints.Expected long-term impact: Through its evidence- and consensus-based framework and recommendations, UNIFIED empowers patients, caregivers, clinicians, industry, regulatory/HTA/reimbursement bodies to make patient-centred healthcare decisions. This will drive measurable improvements across the healthcare ecosystem, benefitting patients, caregivers, clinicians, industry, regulatory/HTA/reimbursement bodies, and society. Ultimately, UNIFIED will enhance patient-centred care by ensuring healthcare decisions reflect true value to patients, thus improving patient outcomes, while ensuring healthcare’s long-term effectiveness and economic sustainability.
Consortium · 51 organisations
ERASMUS UNIVERSITEIT ROTTERDAM
NL · €3,079,810
SIEMENS HEALTHINEERS AG
DE
PFIZER PHARMA GMBH
DE
MEDIZINISCHE UNIVERSITAET WIEN
AT · €600,140
EVINOVA AB
SE
PFIZER LIMITED
UK
JANSSEN CILAG LIMITED
UK
MOLNLYCKE HEALTH CARE AB
SE
HUS-YHTYMA
FI · €599,918
H2O PAN EUROPEAN OBSERVATORY
DK · €140,000
ABBVIE INC
US
ISTITUTO EUROPEO DI ONCOLOGIA SRL
IT · €300,000
Pfizer International Operations
FR
EUROPEAN ACADEMY OF NEUROLOGY
AT · €80,000
UCB BIOPHARMA
BE
PANCARE
NL · €79,875
FORUM DES PATIENTS EUROPEENS
BE · €329,500
Janssen Research & Development, LLC
US
9197-1168 QUEBEC IN
CA
PROMPTLY - SOFTWARE SOLUTIONS FOR HEALTH MEASURES SA
PT · €450,000
John Snow Labs Inc.
US
NOVARTIS PHARMA AG
CH
UNIVERSITEIT TWENTE
NL · €1,099,996
ASTRAZENECA AB
SE
AstraZeneca Pharmaceuticals LP
US
IQVIA LTD
UK
Amgen Inc
US
AMGEN
BE
F. HOFFMANN-LA ROCHE AG
CH
Cassie and Friends: A Society for Children with Juvenile Arthritis and other Rheumatic Diseases
CA · €80,000
Varian Medical Systems Inc.
US
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
NL · €112,878
CHILDHOOD CANCER INTERNATIONAL
NL · €128,563
ASSOCIATION EUROPEENNE POUR LA MALADIE DE PARKINSON
BE · €80,000
PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV
NL · €487,475
UNIVERSITY OF CALGARY
CA · €956,768
UNIVERSITA DEGLI STUDI DI MILANO
IT · €299,175
THE EUROPEAN COALITION FOR PEOPLE LIVING WITH OBESITY COMPANY LIMITED BY GUARANTEE
IE · €80,000
HOCHSCHULE NEUBRANDENBURG
DE · €599,602
PFIZER INC
US
IQVIA SOLUTIONS BELGIUM
BE
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS
IT · €600,000
The Hospital for Sick Children
CA · €16,290
NOVO NORDISK A/S
DK
KATHOLIEKE UNIVERSITEIT LEUVEN
BE · €600,000
FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD M.P.
ES · €250,000
JANSSEN BIOLOGICS BV
NL
COLLABORATE PROJECT MANAGEMENT GMBH
DE · €300,000
UNIVERSITEIT VAN AMSTERDAM
NL · €650,013
Pfizer R&D UK Limited
UK
UNIWERSYTET JAGIELLONSKI
PL · €600,000
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.